Technical Analysis for AKRO - Akero Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
1,2,3 Retracement Bearish | Bearish Swing Setup | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Bearish Engulfing | Bearish | 1.22% | |
Multiple of Ten Bearish | Other | 1.22% | |
Outside Day | Range Expansion | 1.22% | |
Wide Bands | Range Expansion | 1.22% | |
1,2,3 Retracement Bearish | Bearish Swing Setup | -5.06% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -5.06% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Down 1% | 1 day ago |
60 Minute Opening Range Breakdown | 1 day ago |
Possible NR7 | 1 day ago |
Possible Inside Day | 1 day ago |
Rose Above 10 DMA | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/04/2023
Akero Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of transformative treatments for patients with serious metabolic diseases with high unmet medical need. The company's lead program AKR-001 is being evaluated in a Phase 2a clinical trial for the treatment of non-alcoholic steatohepatitis (NASH).
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Alcohol Clinical Trial Steatohepatitis Hepatitis Metabolic Disease Non Alcoholic Fatty Liver Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Alcohol Clinical Trial Steatohepatitis Hepatitis Metabolic Disease Non Alcoholic Fatty Liver Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 54.88 |
52 Week Low | 7.52 |
Average Volume | 561,471 |
200-Day Moving Average | 32.78 |
50-Day Moving Average | 44.09 |
20-Day Moving Average | 40.78 |
10-Day Moving Average | 38.43 |
Average True Range | 2.30 |
RSI | 41.18 |
ADX | 32.24 |
+DI | 11.40 |
-DI | 26.92 |
Chandelier Exit (Long, 3 ATRs) | 41.49 |
Chandelier Exit (Short, 3 ATRs) | 42.27 |
Upper Bollinger Bands | 47.15 |
Lower Bollinger Band | 34.41 |
Percent B (%b) | 0.3 |
BandWidth | 31.23 |
MACD Line | -1.77 |
MACD Signal Line | -1.76 |
MACD Histogram | -0.0153 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 40.69 | ||||
Resistance 3 (R3) | 40.66 | 39.83 | 40.29 | ||
Resistance 2 (R2) | 39.83 | 39.21 | 39.84 | 40.15 | |
Resistance 1 (R1) | 39.04 | 38.83 | 39.44 | 39.07 | 40.01 |
Pivot Point | 38.21 | 38.21 | 38.40 | 38.22 | 38.21 |
Support 1 (S1) | 37.42 | 37.59 | 37.82 | 37.45 | 36.51 |
Support 2 (S2) | 36.59 | 37.21 | 36.60 | 36.37 | |
Support 3 (S3) | 35.80 | 36.59 | 36.24 | ||
Support 4 (S4) | 35.83 |